The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Serotonin Syndrome
Abstract
The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that is responsible for transient serotoninrelated symptoms such as nausea, anxiety, hypertension, tachycardia, visual deficits, motor incoordination, and mild tremors, even at therapeutic doses.”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [42]
In the citing paper
“Both psychedelic effects and serotonin syndrome are associated with an increase in 5-HT2A neurotransmission 42,43”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [42]
In the citing paper
“Serotonin stimulation is known to affect the whole organism not just the brain. It causes vegetative changes such as increase in systolic and diastolic blood pressure, pulse rate, provokes nausea, vomiting, and pupil dilation (Boyer and Shannon, 2005).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Boyer and Shannon, 2005
Citations
Cites
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325
Research works printed but not linked: 8
- Sampson E, 1999, Br J Gen Pract, 49, 867
- Mackay FJ, 1999, Br J Gen Pract, 49, 871
- Hoyer D, 1994, Pharmacol Rev, 46, 157
- Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
- Kline SS, 1989, Clin Pharm, 8, 510
- Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
- Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
- Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744
Cited by
Sorted by citations
Items 601–700 of 1,000
Severe Hypoglycemia Following Venlafaxine Intoxication
Meertens, J. H. J. M., Monteban-Kooistra, W. E., Ligtenberg, J. J. M., Tulleken, J. E., & Zijlstra, J. G. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280311.58495.ee · Cited by 16
The Serotonin Syndrome Complicating Co-prescription of Paroxetine and Clarithromycin
Jaber, B. L., Lobon, L. F., & Madias, N. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.05.022 · Cited by 16
Acute Vilazodone Toxicity in a Pediatric Patient
Acker, E., Sinclair, E. A., Beardsley, A. L., Ahmed, S. S., & Froberg, B. A. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2015.04.032 · Cited by 15
Neurologic complications of anesthesia
Rabinstein, A. A., & Keegan, M. T. (2013) · Neurology Clinical Practice · doi:10.1212/cpj.0b013e3182a1b9bd · Cited by 15
Perioperative analgesia in the elderly
Tedesco, F. D., Sessa, F., Xhemalaj, R., Sollazzi, L., Russo, C. D., & Aceto, P. (2023) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_643_23 · Cited by 15
Selective Serotonin Reuptake Inhibitors and Rhabdomyolysis after Eccentric Exercise
LaBotz, M., WOLFF, T. K., Nakasone, K., Kimura, I. F., Hetzler, R. K., & Nichols, A. W. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000227643.06478.c6 · Cited by 15
Francescangeli, J., Vaida, S. J., & Bonavia, A. S. (2016) · American Journal of Case Reports · doi:10.12659/ajcr.897671 · Cited by 15
Peyrière, H., Eiden, C., Mallaret, M., & Victorri‐Vigneau, C. (2016) · Therapies · doi:10.1016/j.therap.2016.07.001 · Cited by 15
A review of vilazodone exposures with focus on serotonin syndrome effects
Heise, C. W., Malashock, H. R., & Brooks, D. E. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1332369 · Cited by 15
Pediatric Pharmaceutical Ingestions
Lowry, J. A., Burns, M. M., & Calello, D. P. (2017) · Pediatric Annals · doi:10.3928/19382359-20171122-01 · Cited by 15
Moran, G. J., Anda, C. S. D., Das, A., Green, S., Mehra, P., & Prokocimer, P. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0211-4 · Cited by 15
Critical Medical Illness and the Nervous System
Maas, M. B. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000869 · Cited by 15
de Souza, P. A. (2011) · Revista Brasileira de Plantas Medicinais · doi:10.1590/s1516-05722011000300015 · Cited by 21
Santillo, M. F. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.10.009 · Cited by 15
Ma, Z., Rudacille, M., Prentice, H. M., & Tao, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12141 · Cited by 15
Samartzis, L., Savvari, P., Kontogiannis, S., & Dimopoulos, S. K. (2013) · Case Reports in Psychiatry · doi:10.1155/2013/617251 · Cited by 15
Criticisms of drugs in early development for the treatment of depression: what can be improved?
Wang, S., Han, C., & Pae, C. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.985784 · Cited by 15
Serotonin syndrome: a spectrum of toxicity
Ellahi, R. (2015) · BJPsych Advances · doi:10.1192/apt.bp.114.013037 · Cited by 15
Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report
Bostankolu, G., Ayhan, Y., Çetin, F. Ç., & Yazici, M. K. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314561467 · Cited by 15
Lampe, L. A. (2013) · Australian Prescriber · doi:10.18773/austprescr.2013.076 · Cited by 15
Bogodvid, T. K., Andrianov, V. V., Борисовна, Д. И., Николаевна, М. Л., Silantyeva, D. I., Vinarskaya, A. K., Balaban, P. M., & Латыпович, Г. Х. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00403 · Cited by 15
Serotonin Syndrome after Cardiopulmonary Bypass
Hanna, E. R., & Clark, J. A. (2014) · A & A Case Reports · doi:10.1213/xaa.0000000000000010 · Cited by 15
Combination Therapy of Lamotrigine and Escitalopram May Cause Myoclonus
Rosenhagen, M. C., Schmidt, U., Weber, F., & Steiger, A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000219927.49799.c0 · Cited by 15
Gillman, P. K. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2009.03.001 · Cited by 15
Psychedelics, epilepsy, and seizures: a review
Freidel, N., Kreuder, L., Rabinovitch, B. S., Chen, F. Y., Huang, R. S., & Lewis, E. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1326815 · Cited by 14
Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022
Simon, M. W., Olsen, H. A., Hoyte, C. O., Black, J. C., Reynolds, K. M., Dart, R. C., & Monte, A. A. (2024) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2024.06.025 · Cited by 14
Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease
Ngoc, A. P. T., Zahoor, A., Kim, D., & Yang, S. H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2403.03021 · Cited by 16
Existe-t-il un lien entre catatonie et syndrome malin des neuroleptiques ?
Vesperini, S., Papetti, F., & Pringuey, D. (2009) · L Encéphale · doi:10.1016/j.encep.2009.03.009 · Cited by 14
Kirshner, H. S. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0074-7 · Cited by 14
Hyperthermia syndromes in psychiatry
Ahuja, N., & Cole, A. J. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.005090 · Cited by 14
Boushra, M. N., Miller, S. N., Koyfman, A., & Long, B. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.09.035 · Cited by 13
Kruijt, N., van den Bersselaar, L. R., Wijma, J., Verbeeck, W., Coenen, M. J. H., Neville, J., Snoeck, M. M. J., Kamsteeg, E., Jungbluth, H., Kramers, C., et al. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.10.010 · Cited by 14
Gaffney, R. R., & Schreibman, I. R. (2015) · Case Reports in Gastroenterology · doi:10.1159/000382069 · Cited by 14
Serotonin Syndrome with Escitolapram and Concomitant Use of Cocaine: A Case Report
Malik, H. U.-R., & Kumar, K. (2012) · Clinical Medicine Insights Case Reports · doi:10.4137/ccrep.s9540 · Cited by 14
Climate change and the possible health effects on older Australians
Saniotis, A., & Irvine, R. J. (2010) · Australian Journal of Primary Health · doi:10.1071/py10025 · Cited by 14
Lodise, T. P., Patel, N., Rivera, A., Tristani, L., Lazariu, V., VanDeWall, H., & McNutt, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-13 · Cited by 14
Combined effects of fungal alkaloids on intestinal motility in an in vitro rat model1,2
Dalziel, J. E., Dunstan, K. E., & Finch, S. C. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-6449 · Cited by 14
El-Okdi, N., Lumbrezer, D., Karanovic, D., Ghose, A., & Assaly, R. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182456d88 · Cited by 14
Serotonin Syndrome After a Massive Overdose of Controlled-Release Paroxetine
Muzyk, A. J., Jakel, R. J., & Preudʼhomme, X. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70727-1 · Cited by 14
Schumacher, L. D., Blumer, V. L., & Chaparro, S. V. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.05.053 · Cited by 14
Citalopram overdose and severe serotonin syndrome in an intermediate metabolizing patient
Schult, R. F., Morris, A. J., Picard, L., & Wiegand, T. J. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.06.038 · Cited by 14
Halpin, S. N., Potapragada, N. R., Bergquist, S. H., & Jarrett, T. L. (2019) · Educational Gerontology · doi:10.1080/03601277.2019.1698184 · Cited by 14
The teratogenic effects of sertraline in mice
Cabrera, R. M., Lin, Y. L., Law, E., Kim, J., & Wlodarczyk, B. J. (2020) · Birth Defects Research · doi:10.1002/bdr2.1660 · Cited by 14
Basta, M. N. (2020) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253220960255 · Cited by 14
Danquah, A. O., Benjakul, S., & Simpson, B. K. (2012) · doi:10.1002/9781118308035.ch43 · Cited by 14
Understanding Toxidromes: Serotonin Toxicity
Gillman, P. K. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186741.30019.a3 · Cited by 14
Benarroch, E. E. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00690-2 · Cited by 14
Scala, M., Fabbri, C., Fusar-Poli, P., Di Lorenzo, G., Ferrara, M., Amerio, A., Fusar-Poli, L., Pichiecchio, A., Asteggiano, C., Menchetti, M., et al. (2024) · CNS Spectrums · doi:10.1017/s1092852924002268 · Cited by 13
Baumgartner, K. T., Doering, M. M., Mullins, M. E., & on behalf of the Toxicology Investigators Consortium (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2138761 · Cited by 13
Depression Treatment in Pregnancy: Is It Safe, or Is It Not?
Gallitelli, V., Franco, R., Guidi, S., Puri, L., Parasiliti, M., Vidiri, A., Eleftheriou, G., Perelli, F., & Cavaliere, A. F. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21040404 · Cited by 13
Morrison, E. K., & Rowe, A. S. (2012) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2012.01344.x · Cited by 13
“Bath Salts” and the Return of Serotonin Syndrome
Rasimas, J. J. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12com07965 · Cited by 13
Tao, R., Rudacille, M., Zhang, G., & Ma, Z. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.49 · Cited by 13
Meyer, J. M., Cummings, M. A., & Proctor, G. J. (2016) · CNS Spectrums · doi:10.1017/s1092852916000821 · Cited by 13
Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series
Keith, P. D., Saint-Jour, M., Pusey, F. O., Hodges, J., Jalali, F., & Scott, L. K. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x211032089 · Cited by 13
Benzodiazepine Shortages: A Recurrent Challenge in Need of a Solution
Whitledge, J. D., Fox, E. R., & Mazer-Amirshahi, M. E. (2022) · Journal of Medical Toxicology · doi:10.1007/s13181-022-00917-z · Cited by 13
Movement disorder emergencies in the elderly: Recognizing and treating an often-iatrogenic problem
Tousi, B. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.6.449 · Cited by 13
Brantley, E. J., Cohn, J. V., & Babu, K. M. (2009) · Journal of Medical Toxicology · doi:10.1007/bf03161096 · Cited by 13
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge
Decoutere, L., Winter, S. D., Weyden, L. V., Spriet, I., Schrooten, M., Tournoy, J., & Fagard, K. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9666-7 · Cited by 13
Sutton, J., Stroup, J., & Som, M. (2016) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2016.11929423 · Cited by 13
MDMA toxicity: management of acute and life-threatening presentations
Davies, N., English, W., & Gründlingh, J. (2018) · British Journal of Nursing · doi:10.12968/bjon.2018.27.11.616 · Cited by 13
Emergency presentations of movement disorders
Gandhi, S. E., Newman, E. J., & Marshall, V. L. (2020) · Practical Neurology · doi:10.1136/practneurol-2019-002277 · Cited by 13
Knowledge, attitude, and practice (KAP) Study on Serotonin Syndrome Among Neuro Physicians
Prakash, S., Rathore, C., & Rana, K. (2020) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_603_19 · Cited by 13
Ziprasidone, Monoamine Oxidase Inhibitors, and the Serotonin Syndrome
Rim, C. L., & Gitlin, M. J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e63033 · Cited by 13
Migraine: A Question and Answer Review
Evans, R. W. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.09.003 · Cited by 13
Mechanisms of high-dose citalopram-induced death in a rat model
Beaune, S., Callebert, J., Baud, F. J., Risède, P., Juvin, P., & Mégarbane, B. (2012) · Toxicology · doi:10.1016/j.tox.2012.08.006 · Cited by 13
Flavins and Flavoproteins: Applications in Medicine
Jortzik, E., Wang, L., Ma, J., & Becker, K. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0452-5_7 · Cited by 13
Identification and treatment of depression in minority populations
Dejesus, S. A., Diaz, V. A., Gonsalves, W. C., & Carek, P. J. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.1.e · Cited by 11
The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence
Lu, Y., Cheng, Y., Zhu, Y., Cui, L., & Li, X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01320-0 · Cited by 12
Drug-Induced Movement Disorders
Pandey, S., Pitakpatapee, Y., Saengphatrachai, W., Chouksey, A., Tripathi, M., & Srivanitchapoom, P. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1763510 · Cited by 12
Sakai, K., Bradley, E., Zamaria, J. A., Agin-Liebes, G., Kelley, D. P., Fish, A., Martini, V., Ferris, M. C., Morton, E. E., Michalak, E. E., et al. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06585-x · Cited by 15
Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness
Danaf, J. A., Madara, J., & Dietsche, C. L. (2015) · Case Reports in Medicine · doi:10.1155/2015/769576 · Cited by 12
Disorders of Consciousness Induced by Intoxication
Paepe, P. D., Lemoyne, S., & Buylaert, W. A. (2012) · Neurologic Clinics · doi:10.1016/j.ncl.2011.10.003 · Cited by 12
Analgesics use for kidney failure
Sakata, R. K., & Nunes, M. H. G. (2014) · Revista Dor · doi:10.5935/1806-0013.20140048 · Cited by 12
O'Brien, F. E., O’Connor, R. M., Clarke, G. A., Donovan, M. D., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.027 · Cited by 12
Acute Myocardial Infarction Associated with the Serotonin Syndrome
Ganetsky, M., Bird, S. B., & Liang, I. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00019 · Cited by 12
Serotonin syndrome after therapeutic hypothermia for cardiac arrest: A case series
Fugate, J. E., White, R. D., & Rabinstein, A. A. (2014) · Resuscitation · doi:10.1016/j.resuscitation.2014.02.030 · Cited by 12
Is there something more about synthetic cannabinoids?
Yip, L., & Dart, R. C. (2014) · Forensic Toxicology · doi:10.1007/s11419-013-0224-3 · Cited by 12
Valento, M. J., & Lebin, J. A. (2017) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2017.07.009 · Cited by 12
Ortíz, J. F., Wirth, M., Eskander, N., Cozar, J. C., Fatade, O., & Rathod, B. (2020) · Cureus · doi:10.7759/cureus.10635 · Cited by 12
Toxin-Induced Subacute Encephalopathy
Lerner, D. P., Tadevosyan, A., & Burns, J. D. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.07.006 · Cited by 12
Multimodal Analgesic Management for Cervical Spine Surgery in the Ambulatory Setting
Jenkins, N. W., Parrish, J. M., Nolte, M. T., Jadczak, C. N., Mohan, S., Geoghegan, C. E., Hrynewycz, N. M., Podnar, J., Buvanendran, A., & Singh, K. (2021) · The International Journal of Spine Surgery · doi:10.14444/8030 · Cited by 12
Akute Vergiftungen im Erwachsenenalter
Weidhase, L., Hentschel, H., Mende, L., Schulze, G., & Petros, S. (2014) · Der Internist · doi:10.1007/s00108-013-3401-x · Cited by 12
Serotonin syndrome precipitated by sertraline and discontinuation of clozapine
Srisuma, S., Hoyte, C. O., Wongvisawakorn, S., & Wanaukul, W. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1064940 · Cited by 12
Heidland, A., Šebeková, K., Klassen, A., & Palkovits, M. (2010) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.05.011 · Cited by 12
Lam, R. P. K., Leung, K., Wong, T., Lee, H., Tang, M., & Mak, T. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327111431704 · Cited by 12
Patterns of analgesic and anti‐inflammatory medicine use by Australian veterans
Pearson, S., Ringland, C. L., Kelman, C., Mant, A., Lowinger, J., Stark, H., Nichol, G., Day, R. O., & Henry, D. A. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01516.x · Cited by 12
Davis, B. P., Engle, T. E., Ransom, J. I., & Grandin, T. (2016) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2016.12.006 · Cited by 12
Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation
Vichier-Guerre, C., Parker, M. M., Pomerantz, Y., Finnell, R. H., & Cabrera, R. M. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.08.012 · Cited by 12
Tran, H.-Q., Shin, E., Nguyen, B.-C. H., Phan, D.-H., Kang, M.-J., Jang, C., Jeong, J., Nah, S., Mouri, A., Saito, K., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.10.049 · Cited by 11
An atypical case of serotonin syndrome with normal dose of selective serotonin inhibitors
Liu, Y., Yang, H., He, F., Xu, P., Tong, H., Liu, Y. Z., Ni, J., Zhang, Q., & Wang, J. (2019) · Medicine · doi:10.1097/md.0000000000015554 · Cited by 12
Taki, K., Noda, S., Hayashi, Y., Tsuchihashi, H., Ishii, A., & Zaitsu, K. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02645-1 · Cited by 12
The Pitfalls of Psychotropic Polypharmacy
Rothschild, A. J. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001400 · Cited by 12
Management of acute and post-operative pain in chronic kidney disease
Parmar, M. S., & Parmar, K. (2013) · F1000Research · doi:10.12688/f1000research.2-28.v2 · Cited by 12
Antidepressant Discontinuation Syndrome
Kim, S. H., Kim, Y. S., & Kang, U. G. (2024) · 신경정신의학 · doi:10.4306/jknpa.2024.63.2.104 · Cited by 12
The Use of Chemical Restraints for Older Long-Term Hospital Patients: A Case Report from Finland
Nurminen, J., Puustinen, J., Kukola, M., & Kivelä, S. (2009) · Journal of Elder Abuse & Neglect · doi:10.1080/08946560902779860 · Cited by 12
Heneedak, H. M., Salama, I., Mostafa, S. M., Elkady, E. F., & El‐Sadek, M. E. (2014) · Biomedical Chromatography · doi:10.1002/bmc.3384 · Cited by 12
Rahimdel, A., Mellat, A., Zeinali, A., Jafari, E., & Ayatollahi, P. (2014) · Europe PMC (PubMed Central) · Cited by 12
Pharmacogenetic workup of perioperative serotonin syndrome
Beatty, N. C., Nicholson, W. T., Langman, L. J., Curry, T. B., & Eisenach, J. H. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2013.06.005 · Cited by 12
Gressier, F., Ellul, P., Dutech, C., Tayeb, A. E. K. A., Monfort, J., Corruble, E., Becquemont, L., Hardy, P., & Verstuyft, C. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101377 · Cited by 12
Metadata
- Authors
- Boyer, E. W., & Shannon, M.
- Affiliations
- Boston Children's Hospital (US)
- ORCID
- Boyer, Edward W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-17
- Volume
- 352
- Issue
- 11
- Pages
- 1112-1120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2123778879
- Cited by
- 1,821
- References
- 49
- Citations by year
- 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA14929, R21DA014929)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
- MeSH terms
- Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review